MedTrace Logo

Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial

NCT02234830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 818

Last updated 2017-06-01

No results posted yet for this study

Summary

Is the ExoSeal VSD non-inferior to Angio-Seal vascular closure device (VSD) in the incidence of adverse access site related events at 30 days.

Conditions

  • Coronary Disease

Interventions

DEVICE

Exoseal closure device

Closure device for femoral artery access closure

DEVICE

Angioseal closure device

Closure device for femoral artery access closure

Sponsors & Collaborators

  • Cordis Corporation

    collaborator INDUSTRY

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Evald H Christiansen, MD, PhD · Arhus University Hospital Skejby

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-21
Primary Completion
2016-05-14
Completion
2017-05-14

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02234830 on ClinicalTrials.gov